ALDX
Aldeyra Therapeutics, Inc.
1.40$
+3.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,656.6% | +90.6% | +5.7% | +87.6% | +35.6% | -41.6% | +369.9% | -2.1% | +1.6% | -5.0% | +0.9% | |
| – | +7.4% | +26.2% | -1.6% | +52.7% | +95.0% | -12.4% | +0.3% | +16.6% | -30.6% | +38.6% | -23.6% | |
| – | +7.4% | +26.2% | -1.6% | +52.7% | +221.9% | -37.3% | -15.0% | +16.6% | – | – | – | |
| – | -2.4% | -13.8% | -53.5% | +2,220.0% | -45.2% | -422.1% | – | -146.3% | – | +586.6% | -187.6% | |
| – | +512.4% | -86.3% | +109.6% | +962.1% | -96.4% | -99.9% | +156,020.0% | +109.0% | -100.0% | -100.0% | – | |
| – | +92,605.6% | -98.3% | +4,427.7% | +128.8% | – | +57.1% | -100.0% | +383,637.3% | – | -249.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +183.5% | -55.3% | +195.1% | +117.9% | -88.7% | +353.0% | +364.2% | -99.4% | -143.7% | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | -71.9% | -100.0% | |
| – | +183.1% | -55.3% | +193.8% | +115.1% | -70.7% | +77.7% | +364.2% | -99.4% | -204.1% | -86.5% | – | |
| – | +16.3% | -143.0% | – | +241.3% | -110.7% | – | +354.4% | -156.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.